Terpene-based novel invasomes: pioneering cancer treatment strategies in traditional medicine
Author:
Dwivedi Renu12, Bala Rajni2, Madaan Reecha2, Singh Sumitra3, Sindhu Rakesh K.4
Affiliation:
1. School of Pharmaceutical Sciences , Bahra University , Solan , Himachal Pradesh , India 2. Chitkara College of Pharmacy , Chitkara University , Rajpura , Punjab , India 3. Department of Pharmaceutical Sciences , Guru Jambheshwar University of Science and Technology , Hisar , Haryana , India 4. School of Pharmacy , 193167 Sharda University , Greater Noida , Uttar Pradesh , India
Abstract
Abstract
Health care workers have faced a significant challenge because of the rise in cancer incidence around the world during the past 10 years. Among various forms of malignancy skin cancer is most common, so there is need for the creation of an efficient and safe skin cancer treatment that may offer targeted and site-specific tumor penetration, and reduce unintended systemic toxicity. Nanocarriers have thus been employed to get around the issues with traditional anti-cancer drug delivery methods. Invasomes are lipid-based nanovesicles having small amounts of terpenes and ethanol or a mixture of terpenes and penetrate the skin more effectively. Compared to other lipid nanocarriers, invasomes penetrate the skin at a substantially faster rate. Invasomes possess a number of advantages, including improved drug effectiveness, higher compliance, patient convenience, advanced design, multifunctionality, enhanced targeting capabilities, non-invasive delivery methods, potential for combination therapies, and ability to overcome biological barriers,. These attributes position invasomes as a promising and innovative platform for the future of cancer treatment. The current review provides insights into invasomes, with a fresh organizational scheme and incorporates the most recent cancer research, including their composition, historical development and methods of preparation, the penetration mechanism involving effect of various formulation variables and analysis of anticancer mechanism and the application of invasomes.
Publisher
Walter de Gruyter GmbH
Reference101 articles.
1. Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 2021;71:209–49. https://doi.org/10.3322/caac.21660. 2. Sathish, K, Chaturvedi, M, Das, P, Stephen, S, Mathur, P. Cancer incidence estimates for 2022 & projection for 2025: result from national cancer Registry Programme, India. Indian J Med Res 2023;156:598–607. 3. Negoita, SI, Ionescu, RV, Zlati, ML, Antohi, VM, Nechifor, A. New regional dynamic cancer model across the European union. Cancers 2023;15:2545. https://doi.org/10.3390/cancers15092545. 4. Gholami, A, Abdouss, H, Abdouss, M, Rahdar, A, Pandey, MS. Pourmadadi A comprehensive perspective of trastuzumab-based delivery systems for breast cancer treatment. J Drug Deliv Sci Technol 2024;16:105592. 5. Rahmani, M, Pourmadadi, M, Abdouss, M, Rahdar, A, Díez-Pascual, AM. Gelatin/polyethylene glycol/g-C3N4 hydrogel with olive oil as a sustainable and biocompatible nanovehicle for targeted delivery of 5-fluorouracil. Ind Crop Prod 2024;208:117912. https://doi.org/10.1016/j.indcrop.2023.117912.
|
|